vs
FMC CORP（FMC）与高德纳（IT）财务数据对比。点击上方公司名可切换其他公司
高德纳的季度营收约是FMC CORP的1.6倍（$1.8B vs $1.1B），高德纳净利率更高（13.8% vs -158.8%，领先172.7%），高德纳同比增速更快（2.2% vs -11.5%），FMC CORP自由现金流更多（$631.1M vs $270.7M），过去两年高德纳的营收复合增速更高（9.1% vs 8.6%）
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
高德纳是美国专注于商业与科技领域的研究咨询机构，服务客户覆盖大型企业、政府机构、科技公司、投资机构等群体，通过输出研究报告、举办行业峰会、提供定制咨询等形式，为客户决策提供权威专业的洞见支撑。
FMC vs IT — 直观对比
营收规模更大
IT
是对方的1.6倍
$1.1B
营收增速更快
IT
高出13.7%
-11.5%
净利率更高
IT
高出172.7%
-158.8%
自由现金流更多
FMC
多$360.4M
$270.7M
两年增速更快
IT
近两年复合增速
8.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.8B |
| 净利润 | $-1.7B | $242.2M |
| 毛利率 | 39.8% | 67.8% |
| 营业利润率 | -130.8% | 19.1% |
| 净利率 | -158.8% | 13.8% |
| 营收同比 | -11.5% | 2.2% |
| 净利润同比 | -10457.1% | -39.2% |
| 每股收益（稀释后） | $-13.77 | $3.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMCIT
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $542.2M | $1.5B | ||
| Q2 25 | $1.1B | $1.7B | ||
| Q1 25 | $791.4M | $1.5B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.0B | $1.6B | ||
| Q1 24 | $918.0M | $1.5B |
净利润FMCIT
| Q4 25 | $-1.7B | $242.2M | ||
| Q3 25 | $-569.3M | $35.4M | ||
| Q2 25 | $66.7M | $240.8M | ||
| Q1 25 | $-15.5M | $210.9M | ||
| Q4 24 | $-16.3M | $398.6M | ||
| Q3 24 | $65.0M | $415.0M | ||
| Q2 24 | $295.1M | $229.5M | ||
| Q1 24 | $-2.7M | $210.5M |
毛利率FMCIT
| Q4 25 | 39.8% | 67.8% | ||
| Q3 25 | 23.8% | 69.3% | ||
| Q2 25 | 38.7% | 68.6% | ||
| Q1 25 | 40.0% | 69.4% | ||
| Q4 24 | 42.9% | 66.8% | ||
| Q3 24 | 36.3% | 68.4% | ||
| Q2 24 | 38.3% | 68.6% | ||
| Q1 24 | 37.0% | 69.4% |
营业利润率FMCIT
| Q4 25 | -130.8% | 19.1% | ||
| Q3 25 | -73.1% | 5.7% | ||
| Q2 25 | 12.0% | 19.4% | ||
| Q1 25 | 7.4% | 18.1% | ||
| Q4 24 | 19.2% | 18.5% | ||
| Q3 24 | 12.7% | 16.6% | ||
| Q2 24 | 6.0% | 20.0% | ||
| Q1 24 | 8.1% | 18.6% |
净利率FMCIT
| Q4 25 | -158.8% | 13.8% | ||
| Q3 25 | -105.0% | 2.3% | ||
| Q2 25 | 6.3% | 14.3% | ||
| Q1 25 | -2.0% | 13.7% | ||
| Q4 24 | -1.3% | 23.2% | ||
| Q3 24 | 6.1% | 28.0% | ||
| Q2 24 | 28.4% | 14.4% | ||
| Q1 24 | -0.3% | 14.3% |
每股收益（稀释后）FMCIT
| Q4 25 | $-13.77 | $3.36 | ||
| Q3 25 | $-4.52 | $0.47 | ||
| Q2 25 | $0.53 | $3.11 | ||
| Q1 25 | $-0.12 | $2.71 | ||
| Q4 24 | $-0.13 | $5.08 | ||
| Q3 24 | $0.52 | $5.32 | ||
| Q2 24 | $2.35 | $2.93 | ||
| Q1 24 | $-0.02 | $2.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $584.5M | $1.7B |
| 总债务越低越好 | $3.4B | — |
| 股东权益账面价值 | $2.1B | $319.9M |
| 总资产 | $9.7B | $8.1B |
| 负债/权益比越低杠杆越低 | 1.62× | — |
8季度趋势，按日历期对齐
现金及短期投资FMCIT
| Q4 25 | $584.5M | $1.7B | ||
| Q3 25 | $497.7M | $1.4B | ||
| Q2 25 | $438.2M | $2.2B | ||
| Q1 25 | $315.3M | $2.1B | ||
| Q4 24 | $357.3M | $1.9B | ||
| Q3 24 | $416.7M | $1.8B | ||
| Q2 24 | $471.5M | $1.2B | ||
| Q1 24 | $417.8M | $1.2B |
总债务FMCIT
| Q4 25 | $3.4B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.1B | — | ||
| Q1 24 | $3.1B | — |
股东权益FMCIT
| Q4 25 | $2.1B | $319.9M | ||
| Q3 25 | $3.8B | $556.6M | ||
| Q2 25 | $4.4B | $1.5B | ||
| Q1 25 | $4.4B | $1.5B | ||
| Q4 24 | $4.5B | $1.4B | ||
| Q3 24 | $4.6B | $1.1B | ||
| Q2 24 | $4.6B | $646.7M | ||
| Q1 24 | $4.3B | $718.2M |
总资产FMCIT
| Q4 25 | $9.7B | $8.1B | ||
| Q3 25 | $12.1B | $7.2B | ||
| Q2 25 | $12.3B | $8.3B | ||
| Q1 25 | $11.8B | $8.5B | ||
| Q4 24 | $11.7B | $8.5B | ||
| Q3 24 | $12.2B | $7.8B | ||
| Q2 24 | $12.1B | $7.4B | ||
| Q1 24 | $12.0B | $7.7B |
负债/权益比FMCIT
| Q4 25 | 1.62× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.72× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $657.1M | $294.5M |
| 自由现金流经营现金流 - 资本支出 | $631.1M | $270.7M |
| 自由现金流率自由现金流/营收 | 58.3% | 15.4% |
| 资本支出强度资本支出/营收 | 2.4% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 1.22× |
| 过去12个月自由现金流最近4个季度 | $-102.5M | $1.2B |
8季度趋势，按日历期对齐
经营现金流FMCIT
| Q4 25 | $657.1M | $294.5M | ||
| Q3 25 | $-184.2M | $298.7M | ||
| Q2 25 | $65.9M | $383.6M | ||
| Q1 25 | $-545.0M | $313.5M | ||
| Q4 24 | $427.9M | $335.4M | ||
| Q3 24 | $159.5M | $590.8M | ||
| Q2 24 | $292.2M | $370.0M | ||
| Q1 24 | $-142.9M | $188.8M |
自由现金流FMCIT
| Q4 25 | $631.1M | $270.7M | ||
| Q3 25 | $-207.9M | $269.3M | ||
| Q2 25 | $50.9M | $347.3M | ||
| Q1 25 | $-576.6M | $287.9M | ||
| Q4 24 | $406.3M | $311.4M | ||
| Q3 24 | $143.8M | $565.0M | ||
| Q2 24 | $282.3M | $340.6M | ||
| Q1 24 | $-163.6M | $166.2M |
自由现金流率FMCIT
| Q4 25 | 58.3% | 15.4% | ||
| Q3 25 | -38.3% | 17.7% | ||
| Q2 25 | 4.8% | 20.6% | ||
| Q1 25 | -72.9% | 18.8% | ||
| Q4 24 | 33.2% | 18.2% | ||
| Q3 24 | 13.5% | 38.1% | ||
| Q2 24 | 27.2% | 21.4% | ||
| Q1 24 | -17.8% | 11.3% |
资本支出强度FMCIT
| Q4 25 | 2.4% | 1.4% | ||
| Q3 25 | 4.4% | 1.9% | ||
| Q2 25 | 1.4% | 2.1% | ||
| Q1 25 | 4.0% | 1.7% | ||
| Q4 24 | 1.8% | 1.4% | ||
| Q3 24 | 1.5% | 1.7% | ||
| Q2 24 | 1.0% | 1.8% | ||
| Q1 24 | 2.3% | 1.5% |
现金转化率FMCIT
| Q4 25 | — | 1.22× | ||
| Q3 25 | — | 8.45× | ||
| Q2 25 | 0.99× | 1.59× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | 2.45× | 1.42× | ||
| Q2 24 | 0.99× | 1.61× | ||
| Q1 24 | — | 0.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMC
| Insecticides | $440.3M | 41% |
| Herbicides | $378.8M | 35% |
| Fungicides | $140.4M | 13% |
| Plant Health | $65.6M | 6% |
| Other | $45.0M | 4% |
IT
| Transferred Over Time | $1.3B | 73% |
| Conferences | $286.2M | 16% |
| Consulting | $133.6M | 8% |
| Other | $52.3M | 3% |
